Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.13 +0.01 (+0.24%)
At close: Oct 23, 2026 · 4:00 PM EDT

Oramed Pharmaceuticals (ORMP) Cost of Revenue (2016 - 2025)

Updated

Oramed Pharmaceuticals' Cost of Revenue was $1.99 million in FY2025.

Analysis

Oramed Pharmaceuticals (ORMP) Cost of Revenue (2016 - 2025) Analysis & Trends

From FY2016 onward, Oramed Pharmaceuticals has reported Cost of Revenue for 5 years.

  • The FY2025 figure marks the highest annual Cost of Revenue in data going back to FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 Oramed Pharmaceuticals 170.63 Mn -164.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 1.99 Mn
Feb 28, 2019 55,000.00
Nov 30, 2018 35,000.00
May 31, 2018 86,000.00
Nov 30, 2016 187,000.00
Aug 31, 2016 478,000.00
May 31, 2016 8,000.00
Feb 29, 2016 4,000.00
API Access

Oramed Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ORMP&period=max&api_key=YOUR_API_KEY